Log In
Print this Print this

Architect HIV Ag/Ab Combo assay

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionChemiluminescent microparticle immunoassay (CMIA) that detects both the HIV p24 antigen and antibodies to HIV type 1 (HIV-1 group M and group O) and/or type 2 (HIV-2) in human adult and pediatric serum and plasma
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsAid in the diagnosis of HIV-1 and HIV-2 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today